HIF1A and mantle cell lymphoma: The inhibition of proteasome with MG132 (20 μM) resulted in the formation of polyubiquitinated HIF-1α, and MCL-treated H1299 and Calu-1 cells led to more polyubiquitinated forms of HIF-1α when compared with cells without MCL treatment (Figure 4D).